Page last updated: 2024-08-24

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Compensatory Hyperinsulinemia

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Compensatory Hyperinsulinemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, Y; Chen, X; Li, Y; Liu, X; Malki, A; Qian, Y; Wang, X1

Other Studies

1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Compensatory Hyperinsulinemia

ArticleYear
Glucose- and Triglyceride-lowering Dietary Penta-O-galloyl-α-D-Glucose Reduces Expression of PPARγ and C/EBPα, Induces p21-Mediated G1 Phase Cell Cycle Arrest, and Inhibits Adipogenesis in 3T3-L1 Preadipocytes.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2015, Volume: 123, Issue:5

    Topics: 3T3-L1 Cells; Adipocytes, White; Adipogenesis; Animals; Diabetes Mellitus, Type 2; Dietary Supplements; Down-Regulation; Hydrolyzable Tannins; Hyperglycemia; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Obesity; Random Allocation

2015